Zhou Qin, He Yuxiang, Zhao Yajie, Wang Yin, Kuang Weilu, Shen Liangfang
Department of Oncology, Xiangya Hospital, Central South University, No. 87, Xiangya Road, Changsha, Hunan Province 410008, China.
Biomed Res Int. 2017;2017:1419676. doi: 10.1155/2017/1419676. Epub 2017 Feb 7.
To evaluate the rationality and limitations of the seventh edition of the American Joint Committee on Cancer (the 7th AJCC edition) T-staging system for locally advanced nasopharyngeal carcinoma (NPC). The prognosis of 358 patients with stage T3/T4 NPC treated with intensity-modulated radiotherapy (IMRT) was analyzed with the Kaplan-Meier method or the log-rank test. The 7th AJCC staging system of NPC has some limitations in that the T category is neither the significant factor in OS/LRFS nor the independent prognostic factor in OS/LRFS/DMFS/DFS ( > 0.05). After adjustment by anatomic structures, univariate analysis has shown that the adjusted-T category has statistical significance between T3 and T4 for OS (86.4% and 71.3%, = 0.002), LRFS (97% and 90.9%, = 0.048), DMFS (90.9% and 77.2%, = 0.001), and DFS (86.2% and 67.5%, = 0.000), and multivariate analysis has shown that the adjusted-T category is an independent prognostic factor for OS/DMFS/DFS (with the exception of LRFS). Then, GTV-P was taken into consideration. Multivariate analysis showed that these nT categories serve as suitable independent prognostic factors for OS/DMFS/DFS ( < 0.001) and LRFS (HR = 3.131; 95% CI, 1.090-8.990; = 0.043). The 7th AJCC staging system has limitations and should be improved by including the modifications suggested, such as anatomic structures and tumor volume adjustment.
评估美国癌症联合委员会第七版(第7版AJCC)局部晚期鼻咽癌(NPC)T分期系统的合理性和局限性。采用Kaplan-Meier法或对数秩检验分析358例接受调强放疗(IMRT)的T3/T4期NPC患者的预后。第7版AJCC NPC分期系统存在一些局限性,即T类别在总生存期(OS)/局部区域无复发生存期(LRFS)中既不是显著因素,也不是OS/LRFS/远处无复发生存期(DMFS)/无病生存期(DFS)的独立预后因素(>0.05)。经解剖结构调整后,单因素分析显示,调整后的T类别在T3和T4之间对OS(86.4%和71.3%,P = 0.002)、LRFS(97%和90.9%,P = 0.048)、DMFS(90.9%和77.2%,P = 0.001)和DFS(86.2%和67.5%,P = 0.000)具有统计学意义,多因素分析显示调整后的T类别是OS/DMFS/DFS的独立预后因素(LRFS除外)。然后,考虑了大体肿瘤体积(GTV-P)。多因素分析显示,这些nT类别是OS/DMFS/DFS(P < 0.001)和LRFS(风险比[HR]=3.131;95%可信区间[CI],1.090-8.990;P = 0.043)的合适独立预后因素。第7版AJCC分期系统存在局限性,应通过纳入所建议的修改,如解剖结构和肿瘤体积调整来加以改进。